Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of fenofibrate on plasma oxidized LDL and 8-isoprostane in a sub-cohort of GOLDN participants.

Atherosclerosis - 1 Feb 2011

Dong Yan, Steffen Brian T, Cao Jing, Tsai Alexander K, Ordovas Jose, Straka Robert, Zhou Xia, Kabagambe Edmond, Hanson Naomi Q, Arnett Donna, Tsai Michael Y

Abstract excerpt

BACKGROUND: Fenofibrate significantly reduces circulating triglyceride (TG) concentrations, particularly in individuals with elevated levels. The purpose of the current study was to determine whether fenofibrate treatment reduces markers of oxidative stress, oxidized low density lipoprotein (ox-LDL) and 8-isoprostane (8-isoP), in a manner similar to TG where those with the highest levels show the greatest...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atherosclerosis
Share to Biomarkers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Dinoprost

Share to Hypolipidemic Agents

Share to Lipoproteins, LDL

Share to Oxidative Stress

Share to Triglycerides

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 21159339
DOI: 10.1016/j.atherosclerosis.2010.11.022
PMCID: PMC3031718

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of fenofibrate on plasma oxidized LDL and 8-isoprostane in a sub-cohort of GOLDN participants.PMID 21159339Read ↗

Overview of fenofibrate.Semantic proximity Read ↗

Effect of fenofibrate therapy on paraoxonase1 status in patients with low HDL-C levels.Semantic proximity Read ↗

Effect of fenofibrate therapy and ABCA1 polymorphisms on high-density lipoprotein subclasses in the Genetics of Lipid Lowering Drugs and Diet Network.Semantic proximity Read ↗

PPARA Polymorphism Influences the Cardiovascular Benefit of Fenofibrate in Type 2 Diabetes: Findings From ACCORD-Lipid.Semantic proximity Read ↗

Fenofibrate effect on triglyceride and postprandial response of apolipoprotein A5 variants: the GOLDN study.Semantic proximity Read ↗

Genome-wide association study indicates variants associated with insulin signaling and inflammation mediate lipoprotein responses to fenofibrate.Semantic proximity Read ↗

The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart disease.Semantic proximity Read ↗

The PPAR alpha gene is associated with triglyceride, low-density cholesterol and inflammation marker response to fenofibrate intervention: the GOLDN study.Semantic proximity Read ↗

A genome-wide study of lipid response to fenofibrate in Caucasians: a combined analysis of the GOLDN and ACCORD studies.Semantic proximity Read ↗

Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype.Semantic proximity Read ↗

Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN study.Semantic proximity Read ↗

Apolipoprotein B genetic variants modify the response to fenofibrate: a GOLDN study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.